Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.
Anticancer Res
; 43(3): 1265-1272, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36854492
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Thrombocytopenia
/
Neutropenia
Type of study:
Observational_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Anticancer Res
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
Greece